398 related articles for article (PubMed ID: 21083463)
1. Iron-deficiency anemia secondary to mutations in genes controlling hepcidin.
Cau M; Melis MA; Congiu R; Galanello R
Expert Rev Hematol; 2010 Apr; 3(2):205-16. PubMed ID: 21083463
[TBL] [Abstract][Full Text] [Related]
2. [Iron deficiency anaemia due to a matriptase-2 mutation].
Cuijpers ML; Wiegerinck ET; Brouwer R; de Witte TJ; Swinkels DW
Ned Tijdschr Geneeskd; 2010; 154():A1038. PubMed ID: 20719010
[TBL] [Abstract][Full Text] [Related]
3. Haematologic data, iron parameters and molecular findings in two new cases of iron-refractory iron deficiency anaemia.
Tchou I; Diepold M; Pilotto PA; Swinkels D; Neerman-Arbez M; Beris P
Eur J Haematol; 2009 Dec; 83(6):595-602. PubMed ID: 19708871
[TBL] [Abstract][Full Text] [Related]
4. Into the matrix: regulation of the iron regulatory hormone hepcidin by matriptase-2.
Knutson MD
Nutr Rev; 2009 May; 67(5):284-8. PubMed ID: 19386032
[TBL] [Abstract][Full Text] [Related]
5. Liver hemojuvelin protein levels in mice deficient in matriptase-2 (Tmprss6).
Krijt J; Fujikura Y; Ramsay AJ; Velasco G; Nečas E
Blood Cells Mol Dis; 2011 Aug; 47(2):133-7. PubMed ID: 21612955
[TBL] [Abstract][Full Text] [Related]
6. Genetic variability of TMPRSS6 and its association with iron deficiency anaemia.
Delbini P; Vaja V; Graziadei G; Duca L; Nava I; Refaldi C; Cappellini MD
Br J Haematol; 2010 Nov; 151(3):281–4. PubMed ID: 20738301
[TBL] [Abstract][Full Text] [Related]
7. Macrophage iron, hepcidin, and atherosclerotic plaque stability.
Sullivan JL
Exp Biol Med (Maywood); 2007 Sep; 232(8):1014-20. PubMed ID: 17720947
[TBL] [Abstract][Full Text] [Related]
8. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms.
Ramsay AJ; Quesada V; Sanchez M; Garabaya C; Sardà MP; Baiget M; Remacha A; Velasco G; López-Otín C
Hum Mol Genet; 2009 Oct; 18(19):3673-83. PubMed ID: 19592582
[TBL] [Abstract][Full Text] [Related]
9. Fine tuning of hepcidin expression by positive and negative regulators.
Muckenthaler MU
Cell Metab; 2008 Jul; 8(1):1-3. PubMed ID: 18590684
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin in anemia and inflammation in chronic kidney disease.
Malyszko J; Mysliwiec M
Kidney Blood Press Res; 2007; 30(1):15-30. PubMed ID: 17215586
[TBL] [Abstract][Full Text] [Related]
11. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).
Finberg KE; Heeney MM; Campagna DR; Aydinok Y; Pearson HA; Hartman KR; Mayo MM; Samuel SM; Strouse JJ; Markianos K; Andrews NC; Fleming MD
Nat Genet; 2008 May; 40(5):569-71. PubMed ID: 18408718
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin and iron metabolism: from laboratory to clinical implications.
Franchini M; Montagnana M; Lippi G
Clin Chim Acta; 2010 Nov; 411(21-22):1565-9. PubMed ID: 20620132
[TBL] [Abstract][Full Text] [Related]
13. The role of hepcidin in iron homeostasis and anemia in hemodialysis patients.
Eleftheriadis T; Liakopoulos V; Antoniadi G; Kartsios C; Stefanidis I
Semin Dial; 2009; 22(1):70-7. PubMed ID: 19250447
[TBL] [Abstract][Full Text] [Related]
14. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron.
Melis MA; Cau M; Congiu R; Sole G; Barella S; Cao A; Westerman M; Cazzola M; Galanello R
Haematologica; 2008 Oct; 93(10):1473-9. PubMed ID: 18603562
[TBL] [Abstract][Full Text] [Related]
15. Hepcidin--central regulator of iron metabolism.
Atanasiu V; Manolescu B; Stoian I
Eur J Haematol; 2007 Jan; 78(1):1-10. PubMed ID: 17042775
[TBL] [Abstract][Full Text] [Related]
16. Novel mutation in the TMPRSS6 gene with iron-refractory iron deficiency anemia.
Kodama K; Noguchi A; Adachi H; Hebiguchi M; Yano M; Takahashi T
Pediatr Int; 2014 Aug; 56(4):e41-4. PubMed ID: 25252070
[TBL] [Abstract][Full Text] [Related]
17. Iron absorption and metabolism.
Anderson GJ; Frazer DM; McLaren GD
Curr Opin Gastroenterol; 2009 Mar; 25(2):129-35. PubMed ID: 19528880
[TBL] [Abstract][Full Text] [Related]
18. Iron-deficiency anemia in Castleman disease: implication of the interleukin 6/hepcidin pathway.
Arlet JB; Hermine O; Darnige L; Ostland V; Westerman M; Badoual C; Pouchot J; Capron L
Pediatrics; 2010 Dec; 126(6):e1608-12. PubMed ID: 21041280
[TBL] [Abstract][Full Text] [Related]
19. Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis.
Lakhal S; Schödel J; Townsend AR; Pugh CW; Ratcliffe PJ; Mole DR
J Biol Chem; 2011 Feb; 286(6):4090-7. PubMed ID: 20966077
[TBL] [Abstract][Full Text] [Related]
20. Regulation of TMPRSS6 by BMP6 and iron in human cells and mice.
Meynard D; Vaja V; Sun CC; Corradini E; Chen S; López-Otín C; Grgurevic L; Hong CC; Stirnberg M; Gütschow M; Vukicevic S; Babitt JL; Lin HY
Blood; 2011 Jul; 118(3):747-56. PubMed ID: 21622652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
